Preferred Label : Exemestane/Lapatinib/Trastuzumab Regimen;
NCIt synonyms : Exemestane/Trastuzumab/Lapatinib; Exemestane/Lapatinib/Trastuzumab; Exemestane/Trastuzumab/Lapatinib Regimen; Exemestane-Trastuzumab-Lapatinib; Exemestane-Lapatinib-Trastuzumab; Exemestane/Lapatinib/Herceptin; Exemestane-Lapatinib-Trastuzumab Regimen;
NCIt related terms : Exemestane, Lapatinib, Trastuzumab; Exemestane, Lapatinib, Trastuzumab-anns; Exemestane, Lapatinib, Trastuzumab-dkst; Exemestane, Lapatinib, Trastuzumab-qyyp; Exemestane, Lapatinib, Trastuzumab-herw; Exemestane, Lapatinib, Trastuzumab-dttb; Exemestane, Lapatinib, Trastuzumab-pkrb; Exemestane, Lapatinib, Trastuzumab-zerc;
NCIt definition : A regimen consisting of exemestane, lapatinib, and trastuzumab that may be used in
the treatment of breast cancer.;
NCI Metathesaurus CUI : CL563121;
Codes from synonyms : 60436; 128815; 129203; 129106; 129009; 128912; 129300; 129397;
Origin ID : C156303;
UMLS CUI : C4744728;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
